Susquehanna International Group’s Insys Therapeutics, Inc. INSY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-125,600
Closed -$580K 11223
2019
Q1
$580K Buy
125,600
+44,700
+55% +$212K ﹤0.01% 6005
2018
Q4
$283K Sell
80,900
-128,300
-61% -$892K ﹤0.01% 7118
2018
Q3
$2.11M Sell
209,200
-253,700
-55% -$2.02M ﹤0.01% 3894
2018
Q2
$3.35M Buy
462,900
+107,400
+30% +$749K ﹤0.01% 3243
2018
Q1
$2.15M Buy
355,500
+95,400
+37% +$788K ﹤0.01% 3784
2017
Q4
$2.5M Sell
260,100
-32,700
-11% -$214K ﹤0.01% 3524
2017
Q3
$2.6M Sell
292,800
-12,700
-4% -$131K ﹤0.01% 3453
2017
Q2
$3.87M Sell
305,500
-7,700
-2% -$91.1K ﹤0.01% 2755
2017
Q1
$3.29M Sell
313,200
-55,000
-15% -$586K ﹤0.01% 2897
2016
Q4
$3.39M Buy
368,200
+29,600
+9% +$334K ﹤0.01% 3028
2016
Q3
$3.99M Buy
338,600
+35,500
+12% +$540K ﹤0.01% 2515
2016
Q2
$3.92M Sell
303,100
-77,500
-20% -$1.13M ﹤0.01% 2536
2016
Q1
$6.09M Buy
380,600
+84,200
+28% +$1.6M ﹤0.01% 2060
2015
Q4
$8.49M Buy
296,400
+42,300
+17% +$1.17M ﹤0.01% 1921
2015
Q3
$7.23M Sell
254,100
-159,400
-39% -$5.87M ﹤0.01% 2191
2015
Q2
$14.9M Buy
413,500
+301,500
+269% +$9.39M 0.01% 1592
2015
Q1
$3.25M Buy
112,000
+18,800
+20% +$497K ﹤0.01% 3404
2014
Q4
$1.97M Sell
93,200
-261,200
-74% -$5.16M ﹤0.01% 4497
2014
Q3
$6.87M Buy
354,400
+94,500
+36% +$1.48M ﹤0.01% 2573
2014
Q2
$4.06M Buy
259,900
+157,000
+153% +$2.54M ﹤0.01% 3416
2014
Q1
$2.13M Buy
102,900
+51,600
+101% +$1.02M ﹤0.01% 4240
2013
Q4
$662K Buy
+51,300
New +$712K ﹤0.01% 6244

Other funds holding INSY

Susquehanna International Group's INSY Position: Q2 2019 in Review

Susquehanna International Group sold out of Insys Therapeutics, Inc. (INSY) in Q2 2019, closing a stake of 21,561 shares — an estimated $100K sold.

Susquehanna International Group first reported a position in INSY in Q2 2014 and held it in 13 quarters. The position peaked at $1.87M in Q3 2015. 16 funds tracked by Wall St. Rank hold INSY as of Q2 2019.

  • Susquehanna International Group reported no remaining Insys Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
  • Susquehanna International Group sold 21,561 Insys Therapeutics, Inc. shares in Q2 2019, an estimated $100K.
  • Susquehanna International Group first reported a position in Insys Therapeutics, Inc. in Q2 2014 and held it in 13 quarters.
  • Susquehanna International Group's Insys Therapeutics, Inc. position peaked at $1.87M in Q3 2015.
  • 16 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q2 2019.

Based on Susquehanna International Group's 13F filing for Q2 2019, filed 14 Aug 2019.